Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with pci: systematic review and meta-analysis

被引：0
|
作者：
Colombo, F. [1 ]
D'ascenzo, F. [1 ]
Moretti, C. [1 ]
Omede, P. [1 ]
Fox, K. A. A. [2 ]
Rumsfeld, J. S. [3 ]
Tarantini, G. [4 ]
Biondi-Zoccai, G. [5 ]
Gaita, F. [1 ]
机构：
[1] Univ Hosp S Giovanni Battista, Dept Cardiol, Hosp Molinette, Turin, Italy
[2] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[3] Denver VA Med Ctr, Denver, CO USA
[4] Univ Padua, Div Cardiol, Dept Cardiac Thorac & Vasc Sci, Padua, Italy
[5] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, I-00185 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [21] Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis
    Gao, Siyuan
    Zhang, Mei
    Wu, Kaishan
    Zhu, Jianhong
    He, Zhichao
    Li, Jianfang
    Chen, Chuxiong
    Qiu, Kaifeng
    Yu, Xiaoxia
    Wu, Junyan
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 617 - 623
  • [22] UNGUIDED VERSUS GUIDED ALTERATION OF DUAL ANTIPLATELET THERAPY AFTER ACUTE CORONARY SYNDROME: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Fujisaki, Tomohiro
    Kuno, Toshiki
    Shoji, Satoshi
    Sahashi, Yuki
    Takagi, Hisato
    Briasoulis, Alexandros
    Deharo, Pierre
    Cuisset, Thomas
    Latib, Azeem
    Kohsaka, Shun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1024 - 1024
  • [23] New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
    Oldgren, Jonas
    Wallentin, Lars
    Alexander, John H.
    James, Stefan
    Jonelid, Birgitta
    Steg, Gabriel
    Sundstrom, Johan
    EUROPEAN HEART JOURNAL, 2013, 34 (22) : 1670 - 1680
  • [24] Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
    Khan, Safi U.
    Bin Riaz, Irbaz
    Rahman, Hammad
    Lone, Ahmed N.
    Raza, Munis
    Khan, Muhammad Shahzeb
    Riaz, Anum
    Kaluski, Edo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (04) : 429 - 432
  • [25] Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis
    Tritschler, Tobias
    Patel, Anuj
    Kraaijpoel, Noemie
    Bhatt, Deepak L.
    De Luca, Giuseppe
    Di Santo, Pietro
    Feres, Fausto
    Costa, Ricardo A.
    Hibbert, Benjamin
    Isshiki, Takaaki
    Le Gal, Gregoire
    Castellucci, Lana A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (07)
  • [26] Dual Antiplatelet Therapy for Three Months Followed by Monotherapy is Non-inferior to One Year Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention-A Systematic Review and Meta-Analysis
    Anwar, Muhammad Fazeel
    Khan, Behram A.
    Hassan, Syeda Fatima
    Nasreen, Sarwat
    Malik, Saad Ullah
    Fazeel, Hafiz Muhammad
    Din, Asim Tameez Ud
    Chung, Jacqueliene
    Mirza, Mohsin
    CIRCULATION, 2019, 140
  • [27] Systematic review and meta-analysis of optimal P2Y(12) blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome
    Rossington, Jennifer A.
    Brown, Oliver I.
    Hoye, Angela
    OPEN HEART, 2016, 3 (01):
  • [28] The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
    Yang, Yan-Li
    Xiang, Zi-Jian
    Yang, Jing-Hua
    Wang, Wen-Jie
    Xiang, Ruo-Lan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [29] Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events *
    Klingenberg, Roland
    Aghlmandi, Soheila
    Gencer, Baris
    Nanchen, David
    Raber, Lorenz
    Carballo, David
    Carballo, Sebastian
    Stahli, Barbara E.
    Landmesser, Ulf
    Rodondi, Nicolas
    Mach, Francis
    Windecker, Stephan
    Bucher, Heiner C.
    Eckardstein, Arnold von
    Loscher, Thomas F.
    Matter, Christian M.
    ATHEROSCLEROSIS, 2021, 320 : 31 - 37
  • [30] Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet Therapy in PCI Patients: A Systematic Review and Meta-Analysis
    Alagna, Giulia
    Trimarchi, Giancarlo
    Cascone, Alessia
    Villari, Alessio
    Cavolina, Giulia
    Campanella, Francesca
    Micari, Antonino
    Taverna, Giovanni
    Ando, Giuseppe
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 241 : 69 - 74
12345